SIRO Clinpharm Collaborates With Mediscis

SIRO Clinpharm, a global contract research organization (CRO) has reported alliance with Mediscis, an early drug development company based in Poitiers and La Rochelle, France.

Chetan Tamhankar, chief operating officer of SIRO, said: “Following the acquisition of Omega Mediation Clinical Research Services, SIRO was able to establish a footprint in the European clinical research market.

“We envision becoming a leading drug development solutions provider by delivering compelling value propositions to the global healthcare industry. From this alliance, we are glad that we can offer a larger array of services to our global clientele and move closer to our vision.”

Scott Spector, president of strategic operations at Europe, said: “This will be an important collaboration for both the parties as they stand to gain access to each others’ core competencies. This alliance will allow us to provide additional services to our global clients to support their clinical development plans.”